19/04/2014 06:20:20 Free Membership Login

Trinity Biotech News (NASDAQ:TRIB)

DateTimeSource
Headline
04/16/20148:43AMGLOBETrinity Biotech plc to Announce First Quarter Fiscal Year 2014 Financial Results
DUBLIN, April 16, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2014 on Tuesday, April 29, 2014. The Company has scheduled a conference... More...>>
03/04/20149:31AMGLOBETrinity Biotech Announces Results for Q4 and Fiscal Year 2013
DUBLIN, March 4, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for fiscal year 2013 and the quarter ended December 31, 2013. Fiscal year 2013 Results Total revenues for... More...>>
02/19/20148:07AMGLOBETrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2013 Financial Results
DUBLIN, Feb. 19, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter fiscal year 2013 on Tuesday, March 4, 2014. The Company has scheduled a conference... More...>>
01/29/20148:27AMGLOBETrinity Biotech Announces European Approval of Guideline Compliant, Point-of-Care, High Sensitivity Troponin I Product
DUBLIN, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB) today announced it has obtained the CE mark (i.e. European approval) for its Meritas, high sensitivity Troponin I (hsTnI) product. With its unrivalled precision, it is now the only point-of-care product capable of meeting all of the guidelines... More...>>
10/17/20139:27AMGLOBETrinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2...
DUBLIN, Ireland, Oct. 17, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2013, the acquisition of the blood bank screening business... More...>>
10/02/20135:05PMZACKSLIFE, ACD Pen Global Distribution Pact - Analyst Blog
Life Technologies Corporation (LIFE) entered into a global distribution agreement with Advanced Cell Diagnostics (ACD) to commercialize the latter's fluorescent RNAscope portfolio of probes and kits in the research market. Life Technologies will distribute ACD's portfolio through its widespread global distribution... More...>>
09/30/20137:34AMGLOBETrinity Biotech plc to Announce Third Quarter Fiscal Year 2013 Financial Results
DUBLIN, Ireland, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal year 2013 on Thursday, October 17, 2013. The Company has scheduled... More...>>
07/30/20139:38AMGLOBETrinity Biotech Announces Quarter 2 Financial Results and Acquisition of Immco Diagnostics Inc.
DUBLIN, Ireland, July 30, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2013 and the acquisition of Immco Diagnostics Inc. Quarter 2 Results... More...>>
07/23/201310:29AMGLOBETrinity Biotech plc to Announce Second Quarter Fiscal Year 2013 Financial Results
DUBLIN, Ireland, July 23, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2013 on Tuesday, July 30, 2013. The Company has scheduled... More...>>
04/25/20138:34AMGLOBETrinity Biotech Announces Quarter 1 Results - EPS of 20 Cents, Premier Regulatory Approval in China and 33% Increase in Dividen
DUBLIN, Ireland, April 25, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2013. Quarter 1 Results Total revenues for Q1, 2013 were $20.3m... More...>>
04/16/20135:50AMGLOBETrinity Biotech plc to Announce First Quarter Fiscal Year 2013 Financial Results
DUBLIN, Ireland, April 16, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2013 on Thursday, April 25, 2013. The Company has scheduled... More...>>
03/05/20137:17AMGLOBETrinity Biotech Announces Results for Fiscal Year 2012
DUBLIN, Ireland, March 5, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point of care and clinical laboratory markets, today announced results for fiscal year 2012 and for the quarter ended December 31, 2012. Fiscal year 2012 Results Total... More...>>
02/20/201311:00AMGLOBETrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2012 Financial Results
DUBLIN, Ireland, Feb. 20, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2012 on Tuesday, March 5, 2013. The Company has scheduled... More...>>
10/18/20128:02AMGLOBETrinity Biotech Announces Quarter 3 Financial Results
Profit After Tax increases by 13% to $4.5m EPS increases by 12% to 20.7 cents per ADR DUBLIN, Ireland, Oct. 18, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter... More...>>
10/04/20125:29AMGLOBETrinity Biotech plc to Announce Third Quarter Fiscal Year 2012 Financial Results
DUBLIN, Ireland, Oct. 4, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter of fiscal year 2012 on Thursday, October 18, 2012. The Company has scheduled... More...>>
08/02/20128:00PMZACKSTrinity Biotech - Momentum
Trinity Biotech plc (TRIB), which has delivered eight positive earnings surprises in the last ten quarters, is currently hovering around its 52-week high of $12.76 hit on July 16. ADRs of this Ireland-based diagnostic test kits and instrument company have been moving mostly upward since mid-June based on second-quarter... More...>>
07/12/20127:59AMGLOBETrinity Biotech Announces Quarter 2 Financial Results EPS of 20 Cents Per ADR -- an Increase of 11%
DUBLIN, Ireland, July 12, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2012. Quarter 2 Results                                                                                     ... More...>>
07/05/20127:07AMGLOBETrinity Biotech plc to Announce Second Quarter Fiscal Year 2012 Financial Results
DUBLIN, Ireland, July 5, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of fiscal year 2012 on Thursday, July 12, 2012. The Company has scheduled... More...>>
06/26/201212:02PMGLOBETrinity Biotech Added to Membership of Russell Global Index
DUBLIN, Ireland, June 26, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced it has been added as a member of the Russell Global Index as Russell Investments reconstituted its comprehensive... More...>>
06/06/20127:00AMGLOBETrinity Biotech plc Announces Details of Its Dividend and Share Buyback Program
DUBLIN, Ireland, June 6, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced additional details of its Dividend and Share Buyback Program. Annual Dividend At its most recent AGM held on 25... More...>>


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq trib140419 06:20